Wyeth | Evaluate

January 05, 2017

Event – Roche has Aphinity for Perjeta trial success, but not Puma

September 21, 2016

Allergan’s second move spells showdown with Intercept and Gilead

September 20, 2016

Expect Glaxo to increase consumer focus as Walmsley takes driving seat

August 16, 2016

Slimmed-down big pharma starts growing again

July 28, 2016

TauRx touts second chance to prove success

July 22, 2016

Puma files, and the battle begins

July 20, 2016

The end of another chapter in obesity drug development

December 15, 2015

Analysts see a new hope in three-year ExteNET data

November 24, 2015

Pfizer: The once and future M&A king

June 02, 2015

Asco – Puma might have to rely on extended follow-up

May 26, 2015

Speciality players define M&A as big pharma seeks focus

Load More